Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
This study will evaluate patients who have coronary heart disease to determine if an
 investigational drug will further lower cholesterol when taken in combination with an
 approved cholesterol lowering medication.
The duration of treatment is 10 weeks.
Inclusion Criteria:

 -  Patients with elevated cholesterol and coronary heart disease

 Exclusion Criteria:

 -  Patients who do not meet specific cholesterol levels as required by the study